Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Charles H. Sherwood currently holds 189,891 shares of Anika Therapeutics, Inc. (ANIK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Charles H. Sherwood has been a net seller of ANIK stock. They have purchased $0 and sold $22.3M worth of shares.
Charles H. Sherwood's most recent insider trade was on Jan 24, 2018, when they sold 57,100 shares at $0.00 per share.
Charles H. Sherwood serves as Executive at Anika Therapeutics, Inc. (ANIK). They have executed 211 insider transactions totaling $22.3M over their tenure at the company.
Charles H. Sherwood holds the position of Executive at Anika Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Charles H. Sherwood has shown a selling trading pattern, with $0 in total purchases and $22.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Charles H. Sherwood was on May 5, 2014, when they sold $9.0M worth of ANIK shares. This transaction involved 189,381 shares at $47.46 per share.
Charles H. Sherwood currently owns 189,891 shares of Anika Therapeutics, Inc. (ANIK), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Charles H. Sherwood's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Charles H. Sherwood has 211 Form 4 filings on record as an insider at Anika Therapeutics, Inc..
Set alerts for Charles H. Sherwood and 40,000+ other insiders.